Chemical Synthesis and Antigenicity Evaluation of an Aminoglycoside Trisaccharide Repeating Unit of Pseudomonas aeruginosa Serotype O5 O-Antigen Containing a Rare Dimeric-ManpN3NA
- 1 July 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (27) , 18427-18439
Abstract
Pseudomonas aeruginosa bacteria are becoming increasingly resistant against multiple antibiotics. Therefore, the development of vaccines to prevent infections with these bacteria is an urgent medical need. While the immunological activity of lipopolysaccharide O-antigens in P. aeruginosa is well-known, the specific protective epitopes remain unidentified. Herein, we present the first chemical synthesis of highly functionalized aminoglycoside trisaccharide 1 and its acetamido derivative 2 found in the P. aeruginosa serotype O5 O-antigen. The synthesis of the trisaccharide targets is based on balancing the reactivity of disaccharide acceptors and monosaccharide donors. Glycosylations were analyzed by quantifying the reactivity of the hydroxyl group of the disaccharide acceptor using the orbital-weighted Fukui function and dual descriptor. The stereoselective formation of 1,2-cis-α-fucosylamine linkages was achieved through a combination of remote acyl participation and reagent modulation. The simultaneous SN2 substitution of azide groups at C2' and C2″ enabled the efficient synthesis of 1,2-cis-β-linkages for both 2,3-diamino-D-mannuronic acids. Through a strategic orthogonal modification, the five amino groups on target trisaccharide 1 were equipped with a rare acetamidino (Am) and four acetyl (Ac) groups. Glycan microarray analyses of sera from patients infected with P. aeruginosa indicated that trisaccharides 1 and 2 are key antigenic epitopes of the serotype O5 O-antigen. The acetamidino group is not an essential determinant of antibody binding. The β-D-ManpNAc3NAcA residue is a key motif for the antigenicity of serotype O5 O-antigen. These findings serve as a foundation for the development of glycoconjugate vaccines targeting P. aeruginosa serotype O5.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFC2308000)
- Max-Planck-Gesellschaft
- National Natural Science Foundation of China (22077052, 22107037, 22177041, 22207042, 22277042, 22325803)
- Higher Education Discipline Innovation Project (111-2-06)
This publication has 67 references indexed in Scilit:
- Stereoselective Synthesis of the O‐antigen of A. baumannii ATCC 17961 Using Long‐Range Levulinoyl Group ParticipationAngewandte Chemie International Edition, 2023
- Semi‐Synthetic Glycoconjugate Vaccine Lead Against Acinetobacter baumannii 17978Angewandte Chemie International Edition, 2022
- Chemical Synthesis and Antigenic Evaluation of Inner Core Oligosaccharides from Acinetobacter baumannii LipopolysaccharideAngewandte Chemie International Edition, 2022
- Total Syntheses of Conjugation‐Ready Repeating Units of Acinetobacter baumannii AB5075 for Glycoconjugate Vaccine DevelopmentChemistry – A European Journal, 2021
- Merging Reagent Modulation and Remote Anchimeric Assistance for Glycosylation: Highly Stereoselective Synthesis of α‐Glycans up to a 30‐merAngewandte Chemie International Edition, 2021
- Chemical Synthesis and Immunological Evaluation of Helicobacter pylori Serotype O6 Tridecasaccharide O‐Antigen Containing a dd‐HeptoglycanAngewandte Chemie International Edition, 2020
- Chemical Synthesis and Immunological Evaluation of a Pentasaccharide Bearing Multiple Rare Sugars as a Potential Anti‐pertussis VaccineAngewandte Chemie International Edition, 2020
- Stereoselective Glycosylation Reactions with Chiral AuxiliariesAngewandte Chemie International Edition, 2005
- Controlled prospective trial ofPseudomonas aeruginosa vaccine in children with acute leukemiaCancer, 1973
- Immunological Control of Pseudomonas Infection in Burn Patients: A Clinical EvaluationArchives of Surgery, 1971